Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 231

    1.

    Induction of tolerance in type 1 diabetes via both CD4+CD25+ T regulatory cells and T regulatory type 1 cells.

    Battaglia M, Stabilini A, Draghici E, Migliavacca B, Gregori S, Bonifacio E, Roncarolo MG.

    Diabetes. 2006 Jun;55(6):1571-80.PMID: 16731819 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.

    Tian B, Hao J, Zhang Y, Tian L, Yi H, O'Brien TD, Sutherland DE, Hering BJ, Guo Z.

    Transplantation. 2009 Jan 27;87(2):198-206.PMID: 19155973 [PubMed - indexed for MEDLINE]Related articles

    3.

    Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25- CD4+ regulatory T cells.

    Sun JB, Raghavan S, Sjöling A, Lundin S, Holmgren J.

    J Immunol. 2006 Dec 1;177(11):7634-44.PMID: 17114433 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.

    Mellanby RJ, Thomas D, Phillips JM, Cooke A.

    Immunology. 2007 May;121(1):15-28.PMID: 17428252 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.
    6.

    Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis.

    Yu QT, Saruta M, Avanesyan A, Fleshner PR, Banham AH, Papadakis KA.

    Inflamm Bowel Dis. 2007 Feb;13(2):191-9.PMID: 17206665 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Dendritic cells with TGF-beta1 differentiate naive CD4+CD25- T cells into islet-protective Foxp3+ regulatory T cells.

    Luo X, Tarbell KV, Yang H, Pothoven K, Bailey SL, Ding R, Steinman RM, Suthanthiran M.

    Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2821-6. Epub 2007 Feb 16.PMID: 17307871 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.

    Tarbell KV, Petit L, Zuo X, Toy P, Luo X, Mqadmi A, Yang H, Suthanthiran M, Mojsov S, Steinman RM.

    J Exp Med. 2007 Jan 22;204(1):191-201. Epub 2007 Jan 8.PMID: 17210729 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    [Changes of regulatory T cell number in hepatocellular carcinoma-bearing mice and its relationship with tumor growth]

    Zhang P, Zhang LN, Zhu FL, Wang Q, Wang XY, Li HY, Liu CM, Gao F, Liu CH.

    Zhonghua Zhong Liu Za Zhi. 2007 May;29(5):342-5. Chinese. PMID: 17892128 [PubMed - indexed for MEDLINE]Related articles

    10.

    All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells.

    Van YH, Lee WH, Ortiz S, Lee MH, Qin HJ, Liu CP.

    Diabetes. 2009 Jan;58(1):146-55. Epub 2008 Nov 4.PMID: 18984738 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.

    Qu Y, Zhang B, Zhao L, Liu G, Ma H, Rao E, Zeng C, Zhao Y.

    Transpl Immunol. 2007 Apr;17(3):153-61. Epub 2007 Jan 24.PMID: 17331841 [PubMed - indexed for MEDLINE]Related articles

    12.

    Loss of invariant chain protects nonobese diabetic mice against type 1 diabetes.

    Mellanby RJ, Koonce CH, Monti A, Phillips JM, Cooke A, Bikoff EK.

    J Immunol. 2006 Dec 1;177(11):7588-98.PMID: 17114428 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    A regulatory CD4+ T cell subset in the BB rat model of autoimmune diabetes expresses neither CD25 nor Foxp3.

    Hillebrands JL, Whalen B, Visser JT, Koning J, Bishop KD, Leif J, Rozing J, Mordes JP, Greiner DL, Rossini AA.

    J Immunol. 2006 Dec 1;177(11):7820-32.PMID: 17114453 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance.

    Battaglia M, Stabilini A, Draghici E, Gregori S, Mocchetti C, Bonifacio E, Roncarolo MG.

    Diabetes. 2006 Jan;55(1):40-9.PMID: 16380475 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.

    Tsang J, Jiang S, Tanriver Y, Leung E, Lombardi G, Lechler RI.

    Int Immunopharmacol. 2006 Dec 20;6(13-14):1883-8. Epub 2006 Sep 1.PMID: 17161341 [PubMed - indexed for MEDLINE]Related articles

    16.

    Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development.

    Gregori S, Giarratana N, Smiroldo S, Adorini L.

    J Immunol. 2003 Oct 15;171(8):4040-7.PMID: 14530324 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.

    You S, Leforban B, Garcia C, Bach JF, Bluestone JA, Chatenoud L.

    Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6335-40. Epub 2007 Mar 26.PMID: 17389382 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Increased natural CD4+CD25+ regulatory T cells and their suppressor activity do not contribute to mortality in murine polymicrobial sepsis.

    Scumpia PO, Delano MJ, Kelly KM, O'Malley KA, Efron PA, McAuliffe PF, Brusko T, Ungaro R, Barker T, Wynn JL, Atkinson MA, Reeves WH, Salzler MJ, Moldawer LL.

    J Immunol. 2006 Dec 1;177(11):7943-9.PMID: 17114466 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.

    Tritt M, Sgouroudis E, d'Hennezel E, Albanese A, Piccirillo CA.

    Diabetes. 2008 Jan;57(1):113-23. Epub 2007 Oct 10.PMID: 17928397 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Impact of protective IL-2 allelic variants on CD4+ Foxp3+ regulatory T cell function in situ and resistance to autoimmune diabetes in NOD mice.

    Sgouroudis E, Albanese A, Piccirillo CA.

    J Immunol. 2008 Nov 1;181(9):6283-92.PMID: 18941219 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data